Last updated on February 2019

Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Malignant neoplasm of prostate
  • Age: Between 50 - 100 Years
  • Gender: Male

Inclusion Criteria:

  • 50 years of age
  • Clinical suspicion for prostate cancer
  • Elevated Prostate-specific antigen between: 2.0 - 10 ng/ mL
  • No clinical history of a prior negative biopsy

Exclusion Criteria:

  • History of prior prostate biopsy.
  • Use of medications or hormones that are known to affect serum Prostate-specific antigen levels within 3-6 months of study enrollment.
  • Clinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.
  • History of prostate cancer.
  • History of invasive treatments for benign prostatic hypertrophy (Benign Prostatic Hyperplasia) or lower urinary track symptoms within 6 months of study enrollment.
  • No known hepatitis (all types) and/or HIV documented in patient's medical record.
  • Patients with history of concurrent renal/bladder tumors.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.